Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains

SA Rella, YA Kulikova, ET Dermitzakis… - Scientific Reports, 2021 - nature.com
Vaccines are thought to be the best available solution for controlling the ongoing SARS-CoV-
2 pandemic. However, the emergence of vaccine-resistant strains may come too rapidly for …

Science's Response to CoVID‐19

MJC Long, Y Aye - ChemMedChem, 2021 - Wiley Online Library
CoVID‐19 is a multi‐symptomatic disease which has made a global impact due to its ability
to spread rapidly, and its relatively high mortality rate. Beyond the heroic efforts to develop …

Persistence of antibody and cellular immune responses in coronavirus disease 2019 patients over nine months after infection

L Yao, GL Wang, Y Shen, ZY Wang… - The Journal of …, 2021 - academic.oup.com
Background The duration of humoral and T and B cell response after the infection of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. Methods We …

[PDF][PDF] COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects

RSY Wong - The Malaysian journal of pathology, 2021 - mjpath.org.my
Abstract The coronavirus disease 2019 (COVID-19) is one of the biggest public health
threats in the 21st century. Nearly every country in the world has been affected by COVID …

Primary, recall, and decay kinetics of SARS-CoV-2 vaccine antibody responses

FJ Ibarrondo, C Hofmann, JA Fulcher… - ACS …, 2021 - ACS Publications
Studies of two SARS-CoV-2 mRNA vaccines suggested that they yield∼ 95% protection
from symptomatic infection at least short-term, but important clinical questions remain. It is …

[HTML][HTML] Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post–COVID-19 syndrome

X Jia, S Cao, AS Lee, M Manohar, SB Sindher… - JCI insight, 2022 - ncbi.nlm.nih.gov
BACKGROUND Prolonged symptoms after SARS-CoV-2 infection are well documented.
However, which factors influence development of long-term symptoms, how symptoms vary …

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection

EHY Lau, DSC Hui, OTY Tsang, WH Chan… - …, 2021 - thelancet.com
Background The duration of immunity in SARS-CoV-2 infected people remains unclear.
Neutralizing antibody responses are the best available correlate of protection against re …

Scenario analysis of COVID-19 transmission dynamics in Malaysia with the possibility of reinfection and limited medical resources scenarios

AM Salman, I Ahmed, MH Mohd, MS Jamiluddin… - Computers in biology …, 2021 - Elsevier
COVID-19 is a major health threat across the globe, which causes severe acute respiratory
syndrome (SARS), and it is highly contagious with significant mortality. In this study, we …

SARS-CoV-2-directed antibodies persist for more than six months in a cohort with mild to moderate COVID-19

V Glück, S Grobecker, L Tydykov, B Salzberger… - Infection, 2021 - Springer
Objective To follow serological immune responses of front-line healthcare workers after PCR-
confirmed COVID-19 for a mean of 30 weeks, describe the time-course of SARS-CoV-2 …

The pandemic brain: Neuroinflammation in non-infected individuals during the COVID-19 pandemic

L Brusaferri, Z Alshelh, D Martins, M Kim… - Brain, behavior, and …, 2022 - Elsevier
While COVID-19 research has seen an explosion in the literature, the impact of pandemic-
related societal and lifestyle disruptions on brain health among the uninfected remains …